{"id":111281,"date":"2026-06-16T12:56:10","date_gmt":"2026-06-16T10:56:10","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/gate2brain-firma-una-alianza-estrategica-con-shilpa-biocare-con-una-inversion-de-7-millones-de-euros\/"},"modified":"2026-06-16T14:14:23","modified_gmt":"2026-06-16T12:14:23","slug":"gate2brain-firma-una-alianza-estrategica-con-shilpa-biocare-con-una-inversion-de-7-millones-de-euros","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/gate2brain-firma-una-alianza-estrategica-con-shilpa-biocare-con-una-inversion-de-7-millones-de-euros\/","title":{"rendered":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros"},"content":{"rendered":"<p><strong><a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/gate2brain-s-l\/\" target=\"_blank\" rel=\"noopener\">Gate2Brain<\/a>, empresa biotecnol\u00f3gica dedicada al desarrollo de tecnolog\u00edas basadas en p\u00e9ptidos para facilitar la administraci\u00f3n de f\u00e1rmacos en enfermedades del sistema nervioso central, con sede en el Parc Cient\u00edfic de la Universitat de Barcelona, ha anunciado una alianza estrat\u00e9gica con Shilpa Biocare Pvt Ltd. La compa\u00f1\u00eda es una filial de Shilpa Medicare Limited, que se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la empresa.<\/strong><\/p>\n<p>El acuerdo representa la mayor inversi\u00f3n captada por Gate2Brain desde su fundaci\u00f3n y consolida el crecimiento alcanzado por la compa\u00f1\u00eda en menos de seis a\u00f1os de actividad. Esta alianza acelerar\u00e1 el desarrollo de G2B-002 y refuerza la validaci\u00f3n de la plataforma tecnol\u00f3gica propietaria de Gate2Brain para el transporte de terapias a trav\u00e9s de la barrera hematoencef\u00e1lica.<\/p>\n<h3><strong>Impulsando G2B-002 y la innovaci\u00f3n en enfermedades del sistema nervioso central<\/strong><\/h3>\n<p>G2B-002, el programa m\u00e1s avanzado de la compa\u00f1\u00eda, es uno de los principales ejes de esta colaboraci\u00f3n. Se trata de un candidato terap\u00e9utico first-in-class para tumores cerebrales agresivos pedi\u00e1tricos y de adultos, que ha recibido la Designaci\u00f3n de Medicamento Hu\u00e9rfano tanto por parte de la FDA como de la EMA. G2B-002 se basa en MiniAp4, la tecnolog\u00eda propietaria de Gate2Brain dise\u00f1ada para facilitar que las terapias atraviesen la barrera hematoencef\u00e1lica y lleguen al cerebro, uno de los principales retos en las enfermedades del sistema nervioso central. Los estudios precl\u00ednicos han demostrado una mejora en el transporte de los tratamientos al cerebro y una reducci\u00f3n de los efectos secundarios en modelos de tumores cerebrales pedi\u00e1tricos.<\/p>\n<p>La colaboraci\u00f3n combina la tecnolog\u00eda de Gate2Brain con el conocimiento y la experiencia de Shilpa en fabricaci\u00f3n, desarrollo CMC y estrategia regulatoria. Juntas, ambas compa\u00f1\u00edas impulsar\u00e1n el desarrollo cl\u00ednico de G2B-002 y ampliar\u00e1n el potencial de la plataforma tecnol\u00f3gica de Gate2Brain en nuevas \u00e1reas terap\u00e9uticas y nuevas aplicaciones en enfermedades del sistema nervioso central.<\/p>\n<p>Este acuerdo abre una nueva etapa en el desarrollo del programa. Asimismo, refuerza la misi\u00f3n de Gate2Brain de abordar necesidades m\u00e9dicas cr\u00edticas no cubiertas en el c\u00e1ncer cerebral pedi\u00e1trico y otras enfermedades del sistema nervioso central, con el objetivo de ampliar las opciones terap\u00e9uticas para los pacientes y sus familias.<\/p>\n<p>\u201cQueremos agradecer el apoyo continuado de nuestros socios institucionales, asesores externos, inversores y business angels. Su confianza y compromiso han sido fundamentales para el desarrollo de Gate2Brain y de su plataforma tecnol\u00f3gica\u201d, afirm\u00f3 la <strong>Dra. Meritxell Teixid\u00f3<\/strong>, CEO y CSO de Gate2Brain.<\/p>\n<p><strong>\u00bb Enlace a la noticia: <\/strong><a href=\"https:\/\/gate2brain.com\/shilpa-biocare-invests-in-gate2brain-to-advance-g2b-002-an-innovative-brain-cancer-therapeutic-candidate\/\" target=\"_blank\" rel=\"noopener\">web de Gate2Brain [+]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gate2Brain, empresa biotecnol\u00f3gica dedicada al desarrollo de tecnolog\u00edas basadas en p\u00e9ptidos para facilitar la administraci\u00f3n de f\u00e1rmacos en enfermedades del sistema nervioso central, con sede en el Parc Cient\u00edfic de&#8230;<\/p>\n","protected":false},"author":14,"featured_media":111284,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[113],"tags":[305],"class_list":["post-111281","post","type-post","status-publish","format-standard","has-post-thumbnail","category-entidades","tag-gate2brain-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"description\" content=\"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-16T10:56:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-16T12:14:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros\",\"datePublished\":\"2026-06-16T10:56:10+00:00\",\"dateModified\":\"2026-06-16T12:14:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/\"},\"wordCount\":490,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1781603019277-1.jpg\",\"keywords\":[\"Gate2Brain\"],\"articleSection\":[\"ENTIDADES\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/\",\"name\":\"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1781603019277-1.jpg\",\"datePublished\":\"2026-06-16T10:56:10+00:00\",\"dateModified\":\"2026-06-16T12:14:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"description\":\"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1781603019277-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/1781603019277-1.jpg\",\"width\":900,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona","description":"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/","og_locale":"es_ES","og_type":"article","og_title":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona","og_description":"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.","og_url":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2026-06-16T10:56:10+00:00","article_modified_time":"2026-06-16T12:14:23+00:00","og_image":[{"width":900,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros","datePublished":"2026-06-16T10:56:10+00:00","dateModified":"2026-06-16T12:14:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/"},"wordCount":490,"image":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg","keywords":["Gate2Brain"],"articleSection":["ENTIDADES"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/","url":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/","name":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg","datePublished":"2026-06-16T10:56:10+00:00","dateModified":"2026-06-16T12:14:23+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"description":"Se incorpora al accionariado de Gate2Brain mediante una inversi\u00f3n de 7 millones de euros y una participaci\u00f3n del 30,4% en la compa\u00f1\u00eda.","breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2026\/06\/1781603019277-1.jpg","width":900,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/gate2brain-signa-una-alianca-estrategica-amb-shilpa-biocare-amb-una-inversio-de-7-milions-deuros\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Gate2Brain firma una alianza estrat\u00e9gica con Shilpa Biocare con una inversi\u00f3n de 7 millones de euros"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/111281","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=111281"}],"version-history":[{"count":2,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/111281\/revisions"}],"predecessor-version":[{"id":111287,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/111281\/revisions\/111287"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/111284"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=111281"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=111281"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=111281"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}